Graf Akcie FOLD (Amicus Therapeutics Inc). Diskuze k akciím FOLD. Aktuální informace FOLD.

Základní informace o společnosti Amicus Therapeutics Inc (Akcie FOLD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.95B
Hodnota podniku (EV) 2.94B
Tržby 281.823M
EBITDA -198.28
Zisk -252.30
Růst v tržbách Q/Q 24.15 %
Růst v tržbách Y/Y 24.18 %
P/E (Cena vůči ziskům) N/A
Forward P/E 19.68
EV/Sales 10.45
EV/EBITDA N/A
EV/EBIT N/A
PEG 8.91
Price/Sales 10.46
P/FCF N/A
Price/Book 10.29
Účetní hodnota na akcii 1.08
Hotovost na akcii 1.82
FCF vůči ceně -6.88 %
Počet zaměstnanců 483
Tržba na zaměstnance 583.484k
Profit margin -106.12 %
Operating margin -73.27 %
Gross margin 88.10 %
EBIT margin -76.81 %
EBITDA margin -70.36 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -5.00 %
EPS - Očekávaný růst příští rok -28.00 %
Return on assets -29.82 %
Return on equity -94.19 %
ROIC -29.00 %
ROCE -32.07 %
Dluhy/Equity 2.10
Čistý dluh/EBITDA 0.14
Current ratio 4.29
Quick Ratio 4.08
Volatilita 4.76
Beta 1.14
RSI 51.92
Cílová cena analytiků 23
Známka akcie (dle analytiků) 1.50
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 266.555M
Procento shortovaných akcií 10.52 %
Short ratio 11.89 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2007
Země United States

Finanční výsledky akcie FOLD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$182.237$91.245$36.93$4.958-$1.224
Cost Of Goods Sold$21.963$14.404$6.236$0.833--
Gross Profit$160.274$76.841$30.694$4.125-$1.224
Research And Development Expenses$286.378$270.902$149.31$104.793$76.943$47.624
SG&A Expenses$169.861$127.2$88.671$71.151$47.269$20.717
Other Operating Income Or Expenses$-3.297$-3.3$-231.105$-6.76$-4.377$-0.1
Operating Expenses$486.274$420.022$478.915$186.848$130.437$69.925
Operating Income$-304.037$-328.777$-441.985$-181.89$-130.437$-68.701
Total Non-Operating Income/Expense$-51.873$-20.312$-7.136$-21.891$-1.681$-1.338
Pre-Tax Income$-355.91$-349.089$-449.121$-203.781$-132.118$-70.039
Income Taxes$0.478$-0.094$-165.119$-3.739-$-1.113
Income After Taxes$-356.388$-348.995$-284.002$-200.042$-132.118$-68.926
Other Income------
Income From Continuous Operations$-356.388$-348.995$-284.002$-200.042$-132.118$-68.926
Income From Discontinued Operations------
Net Income$-356.388$-348.995$-284.002$-200.042$-132.118$-68.926
EBITDA$-296.716$-313.585$-428.689$-175.959$-128.604$-67.154
EBIT$-304.037$-328.777$-441.985$-181.89$-130.437$-68.701
Basic Shares Outstanding24018615313411074
Shares Outstanding24018615313411074
Basic EPS$-1.48$-1.88$-1.85$-1.49$-1.20$-0.93
EPS - Earnings Per Share$-1.48$-1.88$-1.85$-1.49$-1.20$-0.93
# 2020 2019 2018 2017 2016 2015
Current Ratio4.03756.39885.59633.06482.94237.658
Long-term Debt / Capital0.23890.48410.31750.3002-0.0792
Debt/Equity Ratio0.31380.93830.46530.4289-0.1175
Gross Margin87.948184.213983.11483.1989-100
Operating Margin-166.836-360.3233-1196.818-3668.616--5612.827
EBIT Margin-166.836-360.3233-1196.818-3668.616--5612.827
EBITDA Margin-162.8187-343.6736-1160.815-3548.991--5486.438
Pre-Tax Profit Margin-195.3006-382.5842-1216.141-4110.145--5722.141
Net Profit Margin-195.5629-382.4812-769.0279-4034.732--5631.209
Asset Turnover0.21430.11550.05890.0048-0.0058
Inventory Turnover Ratio1.56421.71681.34890.2439--
Receiveable Turnover5.47524.15473.90223.8021--
Days Sales In Receivables66.664187.852893.53895.9984--
ROE - Return On Equity-74.8046-101.7739-80.488-55.5439-37.9831-56.4144
Return On Tangible Equity-127.9082-240.4955-183.1645-123.2135-88.057-62.3398
ROA - Return On Assets-41.9178-44.1793-45.2936-19.2933-14.5443-32.8271
ROI - Return On Investment-56.9374-52.5079-54.9309-38.8722-37.9831-51.9459
Book Value Per Share1.86531.81072.1132.5242.78211.2786
Operating Cash Flow Per Share0.5729-0.221-0.2764-0.2061-0.21690.1988
Free Cash Flow Per Share0.5236-0.2254-0.2616-0.2066-0.25750.2092